Sign in
MBII Stock Price, Chart, Stats & News
Marrone Bio Innovations, Inc.
Save
Marrone Bio Innovations, Inc. (MBII) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
MBII chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 61.49% |
Operating margin | -33.71% |
Pretax margin | -37.26% |
Net margin | -37.36% |
Effective tax rate | -0.27% |
ROA | -19.02% |
ROE | -54.22% |
D/E | 1.26x |
Interest coverage ratio | -9.52x |
MBII valuation
P/E | – |
P/S | – |
P/B | 4.71x |
P/CF | -14.01x |
P/FCF | – |
P/OCF | -14.01x |
PEG | -0.08x |
EV multiple | 1.72x |
About
Marrone Bio Innovations, Inc. (MBII) specializes in the creation, development, and commercialization of biologically-derived products for use in agriculture. The company's product line is strategically designed to bolster crop protection, improve overall plant vitality, and provide essential nutrition for various crops. Their extensive portfolio includes solutions such as Emergen, Foramin (and its ST variant), Optima, Takla, Pacesetter, Ympact, and UBP (and its ST variant), all engineered to enhance crop health, maximize yields, and improve the final quality of produce.
Similar securities
Based on sector and market capitalization
Report issue